One in 20 children are prescribed codeine after undergoing tonsillectomy despite FDA black box warning regarding safety and efficacy issues associated with prescribing the opioid to children after these surgeries.
Adenotonsillectomy Alone May Not Be Enough to Treat Pediatric OSA
Children with small tonsils may not experience the same benefit and may have other sources of obstruction contributing to their OSA
Can Tonsil Size Help Predict Pediatric OSA Severity?
An evaluation of a child with sleep-disordered breathing requires a careful assessment of symptoms as well as tonsil size
Can Tonsil Size Help Predict Pediatric OSA Severity?
A study showed that tonsil size did not correlate with baseline OSA severity, even when adenoid hypertrophy was accounted for in the analysis
Risk of Routine Use of Steroids after Adenotonsillectomy
Does the administration of IV steroids immediately after adenotonsillectomy impact the frequency of post-operative bleeding requiring reoperation?
Literature Review: A Roundup of Important Recent Studies
Adenotonsillectomy in obese children improves AHI but not inflammation; improvements in OSA after weight loss in obese diabetic patients even after weight regain; ESS a viable choice for children with CRS and failed therapies; otolaryngology hospitalist model can work for inpatient practices; enlarged vestibular aqueduct indicates stronger risk of hearing loss progression; patients with VFP thyroidectomy incur high cost of care
Literature Review: A Roundup of Important Recent Studies
Routine ICU admission for all post-surgical OSA patients unnecessary; parent education for adenotonsillectomy risks; resident Facebook postings impact professionalism; no difference in life expectancy with HNSCC imaging modality; nasal steroids effective in chronic rhinosinusitis with polyposis; costs of laryngeal diseases.
Experts Debate Pediatric Airway Issues
In a recent debate-style panel, five otolaryngologists addressed topical clinical issues relating to the pediatric airway ranging from adenotonsillectomy in children with obstructive sleep symptoms, to whether cidofovir should be used as a standard treatment in children with recurrent respiratory papillomas.